{"id":"https://openalex.org/W2139166805","doi":"https://doi.org/10.1067/mcp.2002.127112","title":"Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic\u2010pharmacodynamic models","display_name":"Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic\u2010pharmacodynamic models","alternate_titles":[],"publication_year":2002,"publication_date":"2002-10-01","ids":{"openalex":"https://openalex.org/W2139166805","doi":"https://doi.org/10.1067/mcp.2002.127112","mag":"2139166805","pmid":"https://pubmed.ncbi.nlm.nih.gov/12386637"},"language":"en","primary_location":{"id":"doi:10.1067/mcp.2002.127112","doi":"https://doi.org/10.1067/mcp.2002.127112","is_oa":false,"landing_page_url":"https://doi.org/10.1067/mcp.2002.127112","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139166805"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004272928","display_name":"J. Frank Jen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juif Jen","raw_affiliation_strings":["Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108520641","display_name":"Mark Laughlin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Laughlin","raw_affiliation_strings":["Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111946634","display_name":"Carol Chung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carol Chung","raw_affiliation_strings":["Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022640492","display_name":"Samuel Heft","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samuel Heft","raw_affiliation_strings":["Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108190075","display_name":"Melton B. Affrime","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melton B. Affrime","raw_affiliation_strings":["Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Samir K. Gupta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samir K. Gupta","raw_affiliation_strings":["Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022110262","display_name":"Paul Glue","orcid":"https://orcid.org/0000-0002-7305-2800","observed_orcids":["https://orcid.org/0000-0002-7305-2800"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Glue","raw_affiliation_strings":["Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033591612","display_name":"Gerald Hajian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald Hajian","raw_affiliation_strings":["Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Statistics, Clinical Pharmacology, and Drug Metabolism/Pharmacokinetics, Schering\u2010Plough Research Institute","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.2399,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.87975615,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"72","issue":"4","first_page":"349","last_page":"361"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9800000190734863},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9739999771118164},{"id":"https://openalex.org/keywords/weight-based-dosing","display_name":"weight-based dosing","score":0.7870000004768372},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.7860000133514404},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.9319999814033508},{"id":"https://openalex.org/keywords/population-pharmacokinetic-pharmacodynamic-modeling","display_name":"population pharmacokinetic/pharmacodynamic modeling","score":0.6759999990463257},{"id":"https://openalex.org/keywords/dose-concentration-relationship","display_name":"dose-concentration relationship","score":0.6650000214576721},{"id":"https://openalex.org/keywords/genotype-1","display_name":"genotype 1","score":0.7590000033378601},{"id":"https://openalex.org/keywords/peginterferon-alfa-2b","display_name":"peginterferon alfa-2b","score":0.8349999785423279},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.8629999756813049},{"id":"https://openalex.org/keywords/dose-simulation","display_name":"dose simulation","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.9110327959060669},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.8194483518600464},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7960589528083801},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6733047366142273},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5820270776748657},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.5615522265434265},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5243996977806091},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.520054280757904},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46962761878967285},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4471629858016968},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.43123728036880493},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3901381492614746},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.3237146735191345},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11783316731452942},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016001","descriptor_name":"Confidence Intervals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1067/mcp.2002.127112","doi":"https://doi.org/10.1067/mcp.2002.127112","is_oa":false,"landing_page_url":"https://doi.org/10.1067/mcp.2002.127112","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:12386637","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12386637","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2312384004","https://openalex.org/W59400926","https://openalex.org/W2111403678","https://openalex.org/W1979803297","https://openalex.org/W2029469392","https://openalex.org/W2140111893","https://openalex.org/W2034654277","https://openalex.org/W1981804908","https://openalex.org/W2335017228"],"abstract_inverted_index":{"BACKGROUND:":[0],"Combination":[1],"therapy":[2],"of":[3,18,30,42,56,71,95,123,178,219,226,257,279],"ribavirin":[4,23,51,89,130,258,320],"with":[5,287,324,330],"interferon":[6,10,326],"alfa-2b":[7,11],"and":[8,60,92,107,120,135,164,185,205,231,238,250,268,274,303,309],"pegylated":[9,325],"is":[12],"currently":[13],"approved":[14],"for":[15,102,117,128,156,167,188,196,208,328],"the":[16,40,69,88,93,139,176,217,254,280,307],"treatment":[17],"chronic":[19,331],"hepatitis":[20,332],"C.":[21],"Approved":[22],"dosages":[24],"vary":[25],"from":[26,74,200],"a":[27,75,146,224,291],"fixed":[28,147,281],"dosage":[29,321],"800":[31,186],"mg/d":[32,38,155,166,174,187,195,207,215],"to":[33,49,86,132,202],"as":[34,36,253],"much":[35],"1200":[37,165,206],"on":[39,68,175,216,337],"basis":[41,70,177,218],"body":[43,179,220,261,338],"weight.":[44,339],"OBJECTIVE:":[45],"Our":[46],"objective":[47],"was":[48,84,112],"evaluate":[50],"dosing":[52,141],"strategies":[53,144],"by":[54],"comparison":[55],"their":[57],"relative":[58],"efficacy":[59,134,249],"toxicity":[61,136,251,269,304],"profiles.":[62],"METHODS:":[63],"Three":[64],"models":[65,99,125],"were":[66,100,126,272,298],"developed":[67,101,127],"data":[72],"collected":[73],"large":[76],"phase":[77],"III":[78],"trial.":[79],"A":[80],"population":[81],"pharmacokinetic":[82],"model":[83],"used":[85],"describe":[87],"dose-concentration":[90],"relationship":[91],"influence":[94],"covariates.":[96],"Logistic":[97],"regression":[98],"both":[103,118,248],"sustained":[104],"virologic":[105],"response":[106,119,267,295,302],"hematologic":[108],"toxicity.":[109,121],"Ribavirin":[110],"concentration":[111],"an":[113],"important":[114],"explanatory":[115],"variable":[116],"Simulations":[122],"these":[124],"different":[129],"doses":[131,152,235],"obtain":[133],"profiles":[137],"across":[138],"various":[140],"strategies.":[142],"These":[143],"included":[145],"800-mg/d":[148,282],"dose,":[149],"empiric":[150],"weight-adjusted":[151],"(ie,":[153],"1000":[154,194],"patients":[157,168,189,197,209,286,329],"who":[158,169,190,198,210],"weighed":[159,170,191,199,211],"<":[160,181],"or":[161,182],"=75":[162],"kg":[163,172,213],">75":[171],"[1000/1200":[173],"weights":[180,221],"=75/>75":[183],"kg]":[184],"<65":[192],"kg,":[193,204],"65":[201],"85":[203],">85":[212],"[800/1000/1200":[214],"<65/65-85/>85":[222],"kg]),":[223],"dose":[225,256,264,313],"13":[227],"mg/kg":[228,240],"per":[229,241,311],"day,":[230],"other":[232],"per-body":[233],"weight":[234],"between":[236,306],"9":[237],"16":[239],"day.":[242],"RESULTS:":[243],"Simulation":[244],"results":[245],"showed":[246],"that":[247,271,319],"increased":[252],"milligrams-per-kilogram":[255],"increased.":[259],"The":[260],"weight-based":[262],"800/1000/1200-mg/d":[263,308],"had":[265,290],"overall":[266],"rates":[270,305],"6.3%":[273],"2.5%":[275],"higher":[276],"than":[277],"those":[278],"dose.":[283],"In":[284],"particular,":[285],"genotype-1":[288],"disease":[289],"7.4%":[292],"increase":[293],"in":[294,301],"rate.":[296],"There":[297],"no":[299],"differences":[300],"13-mg/kg":[310],"day":[312],"groups.":[314],"CONCLUSIONS:":[315],"This":[316],"simulation":[317],"suggests":[318],"(in":[322],"combination":[323],"alfa-2b)":[327],"C":[333],"should":[334],"be":[335],"based":[336]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139166805","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
